What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Cancer

PUBLISHER: TechNavio | PRODUCT CODE: 1558512

PUBLISHER: TechNavio | PRODUCT CODE: 1558512

Global NTRK Fusion Gene Positive Advanced Solid Tumor Market 2024-2028

PUBLISHED: August 15, 2024

PAGES: 123 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

NTRK Fusion Gene Positive Advanced Solid Tumor Market 2024-2028

The NTRK fusion gene positive advanced solid tumor market is forecasted to grow by USD 92.6 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the NTRK fusion gene positive advanced solid tumor market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of cancer, increasing focus on the early detection of cancer, and growing demand for molecular diagnostics.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	4.23%
CAGR	4.5%
Incremental Value	$92.6 mn

Technavio's NTRK fusion gene positive advanced solid tumor market is segmented as below:

By Application

Clinical
Research

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the high demand for biomarker-based tests as one of the prime reasons driving the NTRK fusion gene positive advanced solid tumor market growth during the next few years. Also, increase in research and development and advances in technology and emerging treatment strategies will lead to sizable demand in the market.

The report on the NTRK fusion gene positive advanced solid tumor market covers the following areas:

NTRK fusion gene positive advanced solid tumor market sizing
NTRK fusion gene positive advanced solid tumor market forecast
NTRK fusion gene positive advanced solid tumor market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NTRK fusion gene positive advanced solid tumor market vendors that include Bayer AG, Empire Genomics Inc., F. Hoffmann La Roche Ltd., LGC Clinical Diagnostics Inc., NeoGenomics Laboratories Inc., and OncoDNA. Also, the NTRK fusion gene positive advanced solid tumor market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72459

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global NTRK Fusion Gene Positive Advanced Solid Tumor Market 2018 - 2022
- Historic Market Size - Data Table on Global NTRK Fusion Gene Positive Advanced Solid Tumor Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
6.3 Clinical - Market size and forecast 2023-2028
- Chart on Clinical - Market size and forecast 2023-2028 ($ million)
- Data Table on Clinical - Market size and forecast 2023-2028 ($ million)
- Chart on Clinical - Year-over-year growth 2023-2028 (%)
- Data Table on Clinical - Year-over-year growth 2023-2028 (%)
6.4 Research - Market size and forecast 2023-2028
- Chart on Research - Market size and forecast 2023-2028 ($ million)
- Data Table on Research - Market size and forecast 2023-2028 ($ million)
- Chart on Research - Year-over-year growth 2023-2028 (%)
- Data Table on Research - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
11.4 Empire Genomics Inc.
- Empire Genomics Inc. - Overview
- Empire Genomics Inc. - Product / Service
- Empire Genomics Inc. - Key offerings
11.5 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
11.6 LGC Clinical Diagnostics Inc.
- LGC Clinical Diagnostics Inc. - Overview
- LGC Clinical Diagnostics Inc. - Product / Service
- LGC Clinical Diagnostics Inc. - Key offerings
11.7 NeoGenomics Laboratories Inc.
- NeoGenomics Laboratories Inc. - Overview
- NeoGenomics Laboratories Inc. - Business segments
- NeoGenomics Laboratories Inc. - Key news
- NeoGenomics Laboratories Inc. - Key offerings
- NeoGenomics Laboratories Inc. - Segment focus
11.8 OncoDNA SA
- OncoDNA SA - Overview
- OncoDNA SA - Product / Service
- OncoDNA SA - Key offerings

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR72459

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global NTRK Fusion Gene Positive Advanced Solid Tumor Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Clinical - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Clinical - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Clinical - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Clinical - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Research - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Research - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Research - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Research - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity By Geographical Landscape ($ million)
Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: Bayer AG - Overview
Exhibits94: Bayer AG - Business segments
Exhibits95: Bayer AG - Key news
Exhibits96: Bayer AG - Key offerings
Exhibits97: Bayer AG - Segment focus
Exhibits98: Empire Genomics Inc. - Overview
Exhibits99: Empire Genomics Inc. - Product / Service
Exhibits100: Empire Genomics Inc. - Key offerings
Exhibits101: F. Hoffmann La Roche Ltd. - Overview
Exhibits102: F. Hoffmann La Roche Ltd. - Business segments
Exhibits103: F. Hoffmann La Roche Ltd. - Key news
Exhibits104: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits105: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits106: LGC Clinical Diagnostics Inc. - Overview
Exhibits107: LGC Clinical Diagnostics Inc. - Product / Service
Exhibits108: LGC Clinical Diagnostics Inc. - Key offerings
Exhibits109: NeoGenomics Laboratories Inc. - Overview
Exhibits110: NeoGenomics Laboratories Inc. - Business segments
Exhibits111: NeoGenomics Laboratories Inc. - Key news
Exhibits112: NeoGenomics Laboratories Inc. - Key offerings
Exhibits113: NeoGenomics Laboratories Inc. - Segment focus
Exhibits114: OncoDNA SA - Overview
Exhibits115: OncoDNA SA - Product / Service
Exhibits116: OncoDNA SA - Key offerings
Exhibits117: Inclusions checklist
Exhibits118: Exclusions checklist
Exhibits119: Currency conversion rates for US$
Exhibits120: Research methodology
Exhibits121: Information sources
Exhibits122: Data validation
Exhibits123: Validation techniques employed for market sizing
Exhibits124: Data synthesis
Exhibits125: 360 degree market analysis
Exhibits126: List of abbreviations